Reported Standalone quarterly numbers for Panacea Biotec are:Net Sales at Rs 94.59 crore in September 2023 up 94.07% from Rs. 48.74 crore in September 2022.
Quarterly Net Profit at Rs. 3.20 crore in September 2023 up 146.72% from Rs. 6.85 crore in September 2022.
EBITDA stands at Rs. 12.09 crore in September 2023 up 655.62% from Rs. 1.60 crore in September 2022.
Panacea Biotec EPS has increased to Rs. 0.52 in September 2023 from Rs. 1.12 in September 2022.
| Panacea Biotec shares closed at 151.05 on November 21, 2023 (NSE) and has given 28.99% returns over the last 6 months and 9.62% over the last 12 months. |
| Panacea Biotec | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'23 | Jun'23 | Sep'22 | | Net Sales/Income from operations | 94.59 | 89.41 | 48.74 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 94.59 | 89.41 | 48.74 | | EXPENDITURE | | Consumption of Raw Materials | 37.09 | 37.16 | 29.62 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.95 | -2.50 | -13.21 | | Power & Fuel | -- | -- | -- | | Employees Cost | 22.29 | 20.11 | 17.32 | | Depreciation | 5.34 | 5.40 | 6.24 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 26.20 | 27.83 | 21.33 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 4.62 | 1.41 | -12.56 | | Other Income | 2.13 | 3.34 | 7.92 | | P/L Before Int., Excpt. Items & Tax | 6.75 | 4.75 | -4.64 | | Interest | 3.55 | 3.46 | 2.21 | | P/L Before Exceptional Items & Tax | 3.20 | 1.29 | -6.85 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 3.20 | 1.29 | -6.85 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | 3.20 | 1.29 | -6.85 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 3.20 | 1.29 | -6.85 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.52 | 0.21 | -1.12 | | Diluted EPS | 0.52 | 0.21 | -1.12 | | EPS After Extra Ordinary | | Basic EPS | 0.52 | 0.21 | -1.12 | | Diluted EPS | 0.52 | 0.21 | -1.12 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
